Latest Company Financials News

Magmatic Resources has used FY2026 to turn the newly acquired Weebo Gold Project into its main exploration engine, while Fortescue-funded drilling continued to test copper-gold targets at Myall. The company ended the year with $5.54 million in cash, but a larger annual loss and continued exploration spending keep execution and funding firmly in focus.

Orthocell has recorded the first commercial sales of its Remplir nerve repair product in Thailand, opening a new market estimated at US$84 million. The launch gives the company another distributor-led growth channel, although near-term sales are expected to remain modest.

Everest Metals moved Mt Dimer into mining, established a 260,780-ounce Revere gold resource and upgraded its Mt Edon rubidium project in FY2026. Yet the company remains loss-making, has impaired its Mt Dimer development assets and warns that future funding and project cash inflows are needed to support its going-concern assessment.

Aerometrex delivered a landmark FY26 with operating revenue up 12.3% to $26.84 million and EBITDA more than doubling to $7.68 million, driven by a 27.2% jump in MetroMap subscription revenue and a 37.8% rise in Annual Contract Value.

McGrathNicol Restructuring has been appointed voluntary administrators to Australian Pacific Coal and several subsidiaries, signalling a critical phase in the company’s financial and operational review. The Dartbrook Mine sale continues under receivership, with shares remaining suspended.

CSL Limited’s FY2026 results reveal modest revenue growth offset by a multibillion-dollar statutory loss driven by restructuring and impairments, alongside a maintained dividend and a strategic focus on sustainable growth.

Global X Metal Securities Australia Limited has issued a prospectus for five classes of securities tracking gold, silver, platinum, palladium, and a precious metals basket. The securities are physically backed, traded on ASX under AQUA Rules, and managed by JPMorgan Chase Bank.

Neurotech International has secured FDA clearance for its NTI164 Investigational New Drug application and obtained Notices of Allowance for two US patents, advancing its Phase 3 autism spectrum disorder program.

Aeris Resources reported FY26 copper equivalent production of 42.1kt and gold output of 49koz, both comfortably within guidance, while ending the year with a robust cash and receivables balance of $202.3 million.

Orthocell Limited has posted record revenue for FY2026, driven by strong sales growth of Remplir™ and Striate+™ products in Australia, the US, and new international markets, supported by a robust $44.1 million cash position.

Australian Strategic Materials Limited (ASM) shareholders are set to vote on a scheme of arrangement for Energy Fuels Inc. to acquire 100% of ASM shares and options, offering a significant premium and exposure to a vertically integrated rare earth supply chain.

Chrysos Corporation has hit a new milestone with over one million samples processed monthly, driven by expanding lease agreements and deployments of its PhotonAssay technology. The company remains on track for FY26 revenue and EBITDA guidance amid accelerating global growth.